Apogee Therapeutics signs financing deal with Blackstone Life Sciences for up to $1.3 billion

Apogee Therapeutics

Apogee Therapeutics

APGE

0.00
  • Apogee Therapeutics entered a strategic financing collaboration with Blackstone Life Sciences for up to USD 1.3 billion in non-dilutive capital.
  • Package includes up to USD 800 million of synthetic royalty funding tied to low-to-mid single-digit tiered royalties on zumilokibart sales for 15 years.
  • Royalties step down as sales rise, with no royalties on global annual sales above USD 8 billion.
  • Also provides access to up to USD 500 million of senior corporate debt, subject to mutual consent.
  • Apogee withdrew cash runway end-date guidance, citing the new financing alongside USD 1.3 billion in existing cash.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605270631PRIMZONEFULLFEED9727038) on May 27, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.